Providers/Grant Support
This activity is supported by an educational grant from Castle Biosciences, Inc.
Credits Available
- Physicians — maximum of 0.5 AMA PRA Category 1 CreditsTM
All other healthcare professionals completing this course will be issued a statement of participation
Target Audience
This activity has been designed for dermatologists, dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.
Program Overview
This 30-minute Seminar in Depth from the 2025 Fall Clinical Dermatology Conference explores how to interpret gene expression profiling results and apply the insights to treatment strategies for patients with skin cancer. A patient, Leah Adams, joins our expert faculty panel to share her journey with melanoma diagnosis and the impact of gene expression profiling on her treatment course.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Explain how to interpret gene expression profiling (GEP) test results used in the prognostic workup of patients with skin cancers
- Discuss strategies to incorporate results from GEP testing in the clinical decision-making process for patients with skin cancers
- Describe the impact of GEP testing in skin cancer with respect to the patient diagnostic and treatment journey
Faculty
Harrison Nguyen, MD
Harrison Dermatology and Research Group
University of Houston College of Medicine
Houston, TX
Shannon Trotter, DO
Clinical Assistant Professor of Dermatology, Ohio University
Associate Program Director, OhioHealth Dermatology Residency Program
Private Practice Dermatologists of Central States
Columbus, OH
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada, Reno School of Medicine and CMEsquared. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
The Institute for Continuing Healthcare Education designates this live and enduring activity for a maximum of 0.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures of Conflict of Interest
Harrison Nguyen, MD
Advisory Board: Castle Biosciences, Apogee Therapeutics, Amgen, Sun Pharma, Verrica, Novartis, J&J, Dermavant, Pfizer, UCB, Leo Arcutis, Incyte, Galderma
Consultant: J&J
Speakers’ Bureau or Honoaria: Castle Biosciences, Amgen, Sun Pharma, Verrica, Galderma, J&J, Organon, Pfizer, Regeneron, BMS, BI, Leo, Novartis, UCB
Shannon C. Trotter, DO
Grant/Research Support: Castle Biosciences, Amgen, Acelyrin, Abbvie, Vyne, Kymera, Roche, Evommune, Caliway, Insmed
Consultant: Bristol Myers Squibb, SUN Pharma, Castle Biosciences, Boehringer Ingelheim
Speakers’ Bureau or Honoraria: Castle Biosciences, Pfizer, Boehringer Ingelheim, Verrica, SUN Pharma
The University of Nevada, Reno School of Medicine discloses that all relevant conflicts have been satisfactorily mitigated.
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Submit the evaluation form.
Certificates will be immediately available to the participant.
Disclosure of Unlabeled Use
The Institute requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Disclaimer
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Contact Information
For CME questions please contact: [email protected]